These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1889445)

  • 21. Antiarrhythmic and electrophysiologic effects of oral propafenone.
    Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP
    Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of propafenone in the treatment of tachyarrhythmias in children.
    Vignati G; Mauri L; Figini A
    Eur Heart J; 1993 Apr; 14(4):546-50. PubMed ID: 8472721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
    Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR
    Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy assessment for sustained ventricular tachyarrhythmias: how many electropharmacological tests are appropriate?
    Schoels W; Brachmann J; Hug R; Schmitt C; Kuebler W
    Pacing Clin Electrophysiol; 1990 May; 13(5):663-72. PubMed ID: 1693206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose oral sotalol for monomorphic ventricular tachycardia: effects during programmed electrical stimulation and follow-up.
    Jordaens LJ; Palmer A; Clement DL
    Eur Heart J; 1989 Mar; 10(3):218-26. PubMed ID: 2707270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and results of electrophysiologic testing in young adults with ventricular tachycardia or ventricular fibrillation.
    Morady F; Scheinman MM; Hess DS; Chen R; Stanger P
    Am Heart J; 1983 Dec; 106(6):1306-14. PubMed ID: 6650352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
    Waspe LE; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited clinical utility of endomyocardial biopsy in patients presenting with ventricular tachycardia without apparent structural heart disease.
    Oakes DF; Manolis AS; Estes NA
    Clin Cardiol; 1992 Jan; 15(1):24-8. PubMed ID: 1541071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of antiarrhythmic efficacy of propafenone as assessed by programmed electrical stimulation in conscious dogs.
    Todt H; Krumpl G; Krejcy K; Raberger G
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):341-8. PubMed ID: 1378111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics.
    Podczeck A; Borggrefe M; Bartels K; Breithardt G
    Eur Heart J; 1989 Oct; 10(10):928-34. PubMed ID: 2513204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
    Breithardt G; Seipel L; Abendroth RR
    Z Kardiol; 1981 Jul; 70(7):530-5. PubMed ID: 7269732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G; Disertori M; Inama G; Guarnerio M; Bettini R; Durante G; Stirpe E; Furlanello F
    G Ital Cardiol; 1984 Dec; 14(12):972-81. PubMed ID: 6532893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Programmed stimulation in patients with malignant ventricular arrhythmia. II: Individual optimization of anti-arrhythmia therapy].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Apr; 9(2):77-82. PubMed ID: 6714917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillation.
    Echt DS; Shapiro M; Trusso J; Mason JW; Winkle RA
    Am Heart J; 1985 Jan; 109(1):28-33. PubMed ID: 3966329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.